Chiropractors in Somers, CT Accepting Medicare
1 Chiropractors found. Showing 1 - 1
 Mr. George Paul Sulikowski, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 227 Hall Hill Rd, Somers, CT 06071 Phone: 860-749-0220 Fax: 860-763-4940 |
News Archive
Over past 20 years, the percentage of children with ADHD nearly doubles
The number of children diagnosed with attention deficit hyperactivity disorder (ADHD) has reached more than 10 percent, a significant increase during the past 20 years, according to a study released Friday.
Results from study of Rituxan in rheumatoid arthritis show promise
Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.
Non-toxic Salmonella strain could be promising new treatment option for cancer
According to the Centers for Disease Control, 48 million Americans contract foodborne diseases annually, with Salmonella being the leading cause of illness.
Thesis examines infections caused by Anaplasma phagocytophilum in lambs
Erik Georg Granquist's thesis examines infections caused by the bacterium Anaplasma phagocytophilum in lambs. This bacterium is the cause of the disease tick-borne fever in ruminants and granulocytic anaplasmosis in humans. The bacterium is transmitted by ticks and is the indirect cause of considerable animal welfare problems and financial losses in Norwegian sheep farming.
Epitherix identifies potent and selective multiple chemical scaffolds against colorectal carcinoma
Epitherix, LLC, a privately held company focused on the discovery and development of novel Wnt pathway small molecule inhibitors for epithelial and leukemic cancers, today announced that it has identified multiple chemical scaffolds that are potent and selective against colorectal carcinoma. "We're very encouraged by our in vitro and in vivo data, especially considering the difficulty in drugging this pathway to date," said Dr. Osman Kibar, CEO of Epitherix.
› Verified 3 days ago